Article
Dexmedetomidine could ameliorate intestinal mucosal barrier injury in patients via inhibiting intestinal oxidative stress and inflammatory responses
2023-03-29
Abstract excerpt
Dexmedetomidine (Dex), a highly selective α 2 receptor agonist can inhibit excessive inflammatory reaction and. In this study, we will investigate the effects of Dex can protect against intestinal mucosal barrier injury in patients via inhibiting intestinal inflammatory responses. This is a double-blinded randomized placebo-controlled trial. Ninety-four patients with acute intestinal obstruction, aged 33-81 years...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d4a9737d-f227-5aba-a178-3fe005f28fb7
- DOI
- 10.21203/rs.3.rs-2655476/v1
